Skip to main content
. 2019 May 1;26(5):442–451. doi: 10.5551/jat.44255

Fig. 1.

Fig. 1.

Representative intravascular ultrasound images of coronary plaque regression after lipid- and blood pressure-lowering therapy across the baseline high-sensitivity C-reactive protein (hs-CRP) level quartiles. The percentage change in the plaque volume rose progressively with increasing the baseline hs-CRP.